Pioneering Researcher Speaking About Active Surveillance for Prostate Cancer

San Francisco, CA ( – The Answer Cancer Foundation (AnCan) and Us Too International, which sponsor support groups for men with prostate cancer,  announced a series of four webinars, Active Surveillance and Beyond, aimed at men on or considering active surveillance (AS) for low- and intermediate-risk prostate cancer in place of aggressive therapy.

Dr. Peter Carroll, one of the pioneers of the AS approach of monitoring these cancers, will kick off the series on July 30 at 8 p.m. Eastern. His topic is “The Past, Present, and Future of Active Surveillance.” Dr. Carroll stepped down earlier this year as Chair of Urology at the University of California, San Francisco, but remains an active researcher.

Active Surveillance Patients International (ASPI), Prostate Cancer Research Institute (PCRI), and ZERO - The End of Prostate Cancer are co-sponsors of the webinars.

Other webinars in the AS & Beyond series are:

  •  September 29. Dr. Brian Helfand, Division Chief of Urology, NorthShore University HealthSystem, Glenview, Illinois, will discuss where things stand and where they are heading with genomic testing in decision-making for AS.
  • November 30. Dr. Antonio Westphalen, Chief of Abdominal Imaging, the University of Washington at Seattle, will discuss his research on the value of monitoring men on AS with multiparametric MRIs and how to find the best radiologist to read your MRI.
  • December 30. Dr. Jonathan Epstein, Chair of Urological Pathology, The Johns Hopkins Medical Institutions in Baltimore, will speak about critical issues of grading prostate cancer for patients considering AS.

Additional Information:

To register for the July 30 webinar with Dr. Carroll, go here
To submit questions ahead of the July 30 session or for information, write to Joe Gallo at 
The Answer Cancer Foundation (AnCan)